Welcome to the August 2026 edition of the ISODP Journal Watch.

In this edition, we have tried to draw out what we find interesting, question assumptions where warranted, and leave readers with something to think about. This reflects how we see research itself: not as a finished article, but as an ongoing act of critical reflection, where the value of any paper lies as much in the next hypothesis and research question it prompts as in the answers it offers. That is how the field keeps advancing, and how we all advance with it.

If a single thread runs through this edition's selection, it is one of the oldest and most consequential questions in our field: what do we mean by death, and how do we determine it? The papers gathered here approach that question from every direction, from donor biology and transplant outcomes, through law and international consensus, to the conversation that finally matters most: the one at the bedside with a grieving family.

We open at the circulatory end of the spectrum, with a study that challenges a piece of DCD dogma that has gone largely unquestioned for decades — that a shorter time to asystole is always better — and in doing so uncovers a more intriguing signal at the opposite end of the curve, where very rapid progression may identify a biologically distinct group of donors. From there we turn to the neurological determination of death, where the UK's first major revision to its Code of Practice in 17 years has prompted two complementary papers: one on what has changed and how to apply it, and another on how those criteria have acquired legal authority and where uncertainty still remains.

The collection then widens to practice and ethics. From Japan comes an unusually detailed look inside one of the world's most distinctive donation systems, with a lesson that unsettles easy assumptions: the hospitals doing more donation were not faster, but more multidisciplinary, more experienced, and apparently more successful. A systematic review asks why, two decades on, the same ethical concerns about DCD keep returning. Are these concerns barriers to overcome or enduring tensions that mature systems must learn to manage?

The final papers take that question to the international stage. Two Bucharest ESOT consensus papers ask how much of controlled DCD practice the world can actually agree on, and whether global consensus can do more than identify broad common ground between different donation systems.

We close where it all begins, and where all our efforts as donation professionals are put to the test. A study working with families rather than clinicians arrives at a quietly profound reframing: that families asked to accept a determination of death using neurological criteria may need less a transfer of knowledge than a transfer of trust, and that the most important tool remains the clinician who knows the words, uses them consistently, and has practised how to explain death.

As always, we hope these papers inform, provoke and occasionally unsettle. We welcome your thoughts and correspondence.